Systemic purine administration: modulating axonal outgrowth of central nervous system neurons
AssigneeAlseres Pharmaceuticals, Inc.
InventorsNoel James Cusack, Mark R. Hurtt, Richard M. Thorn
Life of this patent
Estimating the term…
Abstract
Methods for modulating the axonal outgrowth of central nervous system neurons are provided by means of internalized purine administration such as by intravenous, intraarterial, subcutaneous, intramuscular, intraperitoneal, and intrapleural administration. The methods are noted for stimulating the axonal outgrowth of central nervous system neurons following an injury (e.g., stroke, traumatic brain injury, cerebral aneurism, spinal cord injury and the like).
Claims2
A method for stimulating the axonal outgrowth of central nervous system neurons following central nervous system injury in a mammal in need thereof, comprising administration of a pharmaceutical composition comprising an effective amount of inosine such that axonal outgrowth is stimulated in vivo,
- further comprising co-administration of a therapeutically effective dosage of an inhibitor of a kinase selected from the group consisting of c-Jun N-terminal kinase (JNK), Rho-associated protein kinase (ROCK) and Ras homolog gene family, member A (RhoA).
A method for stimulating the axonal outgrowth of central nervous system neurons following central nervous system injury in a mammal in need thereof, comprising administration of a pharmaceutical composition comprising an effective amount of inosine such that axonal outgrowth is stimulated in vivo,
- further comprising co-administration of a therapeutically effective dosage of BA-210 C3 exoenzyme fibrin sealant mixture (Cethrin®).
Dependencies are inferred from the claim text.